NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
31 March 2025
| Name: | CLINUVEL PHARMACEUTICALS LIMITED (CUV) | ||||||
| ISIN: | AU000000CUV3 | ||||||
| Date of Listing: | 13 February 2001 | ||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 089 644 119ABN: 88 089 644 119
Registration Date: 14 December 1999
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| CLINUVEL PHARMACEUTICALS LIMITED | 01/03/2006 | |
| EPITAN LIMITED | 01/03/2006 |
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
The suspension of trading in the securities of Clinuvel Pharmaceuticals Limited (the " Company") will be lifted immediately, following the release of an announcement regarding a capital raising. Security Code: CUV | 06/05/2013 |
Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) has successfully raised A$6.3 million via a private placement to international institutional and professional investors ("Placement"). The Placement was conducted at price of A$2.136 per share, representing a 4.3% premium to the 20 day volume weighted average price on April 29 and 15.1% to the closing Price on April 30. There was strong participation in the Placement from institutional investors. | 06/05/2013 |
The securities of Clinuvel Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. Security Code: CUV | 03/05/2013 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 12/11/2010 |
name changed from Epitan Limited | 01/03/2006 |
The suspension of trading in the securities of Clinuvel Pharmaceuticals Limited (the " Company") will be lifted immediately, following the release of an announcement regarding a capital raising. Security Code: CUV | 06/05/2013 |
Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) has successfully raised A$6.3 million via a private placement to international institutional and professional investors ("Placement"). The Placement was conducted at price of A$2.136 per share, representing a 4.3% premium to the 20 day volume weighted average price on April 29 and 15.1% to the closing Price on April 30. There was strong participation in the Placement from institutional investors. | 06/05/2013 |
The securities of Clinuvel Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. Security Code: CUV | 03/05/2013 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 12/11/2010 |
name changed from Epitan Limited | 01/03/2006 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 19/09/2023 | Philippe Wolgen | 1,850 | $16.116 | $29,814 |
| 26/06/2023 | Philippe Wolgen | 1,532 | $17.720 | $27,147 |
| 04/11/2022 | Jeffrey Rosenfeld | 300 | $19.440 | $5,832 |
| 16/06/2022 | Brenda Shanahan | -15,000 | $14.036 | $210,536 |
| 07/06/2022 | Brenda Shanahan | -22,392 | $15.881 | $355,606 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Jeffrey Rosenfeld | Chairman | 26/11/2019 |
| Philippe Wolgen | CEO | 01/10/2005 |
| Peter Vaughan | CFO, Company Secretary | 16/04/2024 |
| Matthew Pringle | Non Exec Director | 06/09/2024 |
| Susan Smith | Non Exec Director | 23/09/2019 |
| Guy van Dievoet | Non Exec Director | 06/09/2024 |
| Pearl Grimes | Non Exec Director | 06/09/2024 |
| Karen Agersborg | Non Exec Director | 29/01/2018 |
| Emilie Rodenburger | Director | 22/04/2024 |
| Claire Newstead-Sinclair | Company Secretary | 06/08/2024 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Brenda Shanahan | Non Exec Director | 06/02/2007 | 16/10/2024 |
| Darren Keamy | CFO, Company Secretary | 07/12/2005 | 28/06/2024 |
| Willem Blijdorp | Non Exec Director | 21/01/2015 | 21/02/2024 |
| Andrew Likierman | Non Exec Director | 04/04/2022 | 31/10/2023 |
| Stanley McLiesh | Non Exec Chairman | 12/09/2002 | 02/12/2020 |
| Elia Ishag | Non Exec Director | 01/02/2011 | 28/11/2017 |
| Jack Wood | Non Exec Director | 08/07/2008 | 28/07/2014 |
| Helmer Agersborg | Executive Director | 22/08/2000 | 28/09/2012 |
| Roger Aston | Non Exec Director | 04/04/2005 | 03/09/2010 |
| Terry Winters | Non Exec Director | 22/08/2000 | 03/06/2007 |
| Wayne Millen | Non Exec Director | 09/12/1999 | 29/11/2006 |
| Iain Kirkwood | Managing Director | 30/11/2005 | |
| Alan Cooper | 02/05/2003 | ||
| Malcolm McComas | Non Exec Director | 17/12/1999 | 02/07/2002 |
| Graeme Salthouse | Chairman | 02/10/2001 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
